Safety and effectiveness of monthly intravenous ibandronate injections in a prospective, postmarketing, and observational study in Japanese patients with osteoporosis

OBJECTIVES: This postmarketing, observational study evaluated the safety and effectiveness of monthly intravenous (IV) ibandronate in Japanese patients with osteoporosis. METHODS: Eligible patients received monthly IV ibandronate 1 mg for 12 months. Adverse drug reactions (ADRs) were evaluated. Chan...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Yasuhiro, Hashimoto, Junko, Nishida, Yosuke, Yamagiwa, Chiemi, Tamura, Takashi, Atsumi, Akihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362972/
https://www.ncbi.nlm.nih.gov/pubmed/30775537
http://dx.doi.org/10.1016/j.afos.2018.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362972/
https://www.ncbi.nlm.nih.gov/pubmed/30775537
http://dx.doi.org/10.1016/j.afos.2018.01.001

Ejemplares similares